Investment Rating - The report maintains a "Positive" investment rating for the healthcare sector [11] Core Insights - The innovative chain sector is entering a new growth cycle driven by both domestic and international demand, with significant improvements expected in China's innovative drug R&D investment starting in 2025 [2][6] - Chinese innovative drug companies are expected to see a substantial increase in available funds, with a projected total of 201.5 billion yuan in IPO fundraising and financing activities in 2025, marking a 145% year-on-year increase [6] - The report highlights the strong performance of CDMO companies, with significant order improvements anticipated by mid-2024, and a positive trend in their financial performance [7] - The innovative drug sector is entering a realization phase with low valuation levels, and numerous catalysts expected in Q2 2026, suggesting a favorable outlook for investments in this area [8] Summary by Sections Domestic Demand - By 2025, the investment climate for innovative drug R&D in China is expected to improve, leading to a new cycle of prosperity in the innovative drug industry [6] - The funding available to Chinese pharmaceutical companies is increasing, with a projected 880.5 billion yuan in potential milestone payments from external business development (BD) activities, a 185.9% year-on-year increase [6] International Demand - CDMO companies focused on overseas revenue are expected to see significant improvements in new orders starting from Q2 2024, with year-on-year growth rates recovering to over 15% [7] - WuXi AppTec's backlog is projected to reach 58 billion yuan by the end of 2025, reflecting a 28.8% year-on-year increase, with expected revenue growth of 18-22% in 2026 [7] Innovative Drug Sector - The innovative drug sector is entering a realization phase with low valuations, supported by a series of policy measures that have been implemented since 2024 [8] - The number of Chinese companies participating in international academic conferences is increasing, with over 100 expected to present nearly 400 research outcomes in 2026 [8] Technological Advancements - Chinese pharmaceutical companies are rapidly enhancing their global competitiveness, with innovative technologies such as second-generation ADCs and molecular therapies being developed at a leading global level [9] - The report suggests that the outbound business development strategies are diversifying, including mergers and collaborations, which could enhance the global presence of Chinese pharmaceutical companies [9]

Market Overview - On April 1, 2026, both stock indices closed lower with a trading volume of 2 trillion, an increase of approximately 70 billion from the previous trading day[1] - The Shanghai Composite Index fell by 6.51% in March, losing the 3900-point mark after initially breaking a high point on January 14[3] - Major sectors such as coal, power equipment, chemicals, and agriculture saw significant declines, while banking, home appliances, and food and beverage sectors experienced slight gains[1] Capital Flow - On March 31, net outflows from the Shanghai Stock Exchange amounted to 19.423 billion, while the Shenzhen Stock Exchange saw net outflows of 17.918 billion[4] - The top three sectors for capital inflow were plastics, rail transit equipment, and large state-owned banks, while the top outflow sectors included semiconductors, batteries, and communication equipment[4] Industry Dynamics - The commercial aerospace sector has seen a notable increase in activity, with the successful launch of the Lijian-2 rocket, which aims to match SpaceX's cost efficiency[2] - The Chinese automotive dealer inventory warning index for March stood at 57.5%, reflecting a year-on-year increase of 2.9 percentage points and a month-on-month increase of 1.3 percentage points[8] Economic Indicators - In February, the China Council for the Promotion of International Trade reported a 72.38% year-on-year increase in the issuance of various certificates, indicating a strong start for foreign trade in 2026[5] - The Ministry of Industry and Information Technology reported that integrated circuit design revenue reached 63.6 billion, a year-on-year growth of 15.7% in the first two months of 2026[9] Investment Insights - Long-term funds are increasingly entering the market, with 156 companies showing involvement from social security funds and 123 from Qualified Foreign Institutional Investors (QFII)[10] - The total trading volume of ETFs reached 453.854 billion, with stock ETFs accounting for 15.961 billion and bond ETFs for 18.852 billion[12]

Group 1 - The article highlights a rebound in the Asia-Pacific stock market, particularly in the biopharmaceutical sector, driven by easing tensions in the US-Iran conflict [1] - The Hang Seng Biotech ETF (513280) surged nearly 6%, with significant trading volume exceeding 220 million yuan, and many constituent stocks, such as Sangfor Biopharma and Innovent Biologics, showing strong gains [1] - The A-share market also saw the Huatai Biopharmaceutical ETF (159839) rise nearly 4%, marking a strong performance with a net inflow of over 180 million yuan in the past 60 days [1] Group 2 - According to Founder Securities, the innovative drug sector is entering a profitability cycle, with leading companies like BeiGene and Innovent Biologics achieving profitability [2] - The total value of innovative drug licensing transactions from China exceeded 60 billion USD in the first three months of this year, indicating accelerated international expansion [2] - A series of international academic conferences are set to take place, providing opportunities for Chinese pharmaceutical companies to present promising data and enhance pipeline value [2] Group 3 - China’s CXO sector is benefiting from improved financing conditions, with a notable reversal in investment trends since early 2025, which is expected to stimulate new rounds of innovative drug research and development [3] - The impact of AI on the pharmaceutical industry is deepening, transitioning from concept to practical application, enhancing efficiency across various segments [3] - The CXO sector is expected to see a recovery in demand driven by improved investment sentiment and increased orders, with a focus on the structural upgrades and integration within the industry [4] Group 4 - The CXO sector's fundamentals are improving, with new orders and demand expected to drive future market performance, supported by favorable conditions in the innovative drug investment landscape [4] - The sector is anticipated to expand due to increasing outsourcing needs in research and production, alongside the emergence of new therapies [5] - AI in drug discovery is projected to reach a critical development point by 2026, further validating its value in early-stage research decisions [5] Group 5 - The Hang Seng Biotech ETF (513280) is noted for its low management fee of 0.15% per year, making it an attractive option for investors looking to capitalize on the biopharmaceutical sector [6] - The ETF tracks 30 leading Hong Kong pharmaceutical stocks, with a balanced focus on innovative drugs and CXO growth opportunities [6] - The ETF has seen a significant increase in net inflows, with a growth rate exceeding 34% for the year [6] Group 6 - The Huatai Biopharmaceutical ETF (159839) focuses on the A-share market, balancing contributions from CXO and innovative drugs, and includes leading companies in the sector [10] - The top ten holdings in the ETF account for over 55% of its total weight, indicating a concentrated investment strategy [10] - The ETF aims to capture opportunities in various sub-sectors, including vaccines and blood products, enhancing its overall market responsiveness [10]

Group 1: Report Industry Investment Rating - Not provided Group 2: Core Viewpoints of the Report - **Stock Index**: The market rebounded after hitting bottom throughout the day, with the three major indices showing mixed performance. There were more rising stocks than falling ones, with over 2,800 stocks rising in the Shanghai, Shenzhen, and Beijing stock markets, and the trading volume was 1.93 trillion yuan. The conflict between the US and Iran and the Fed's interest - rate decision affected the capital market, increasing risk - aversion sentiment. In the medium term, if global technology stocks are affected by liquidity, the previously strong technology sectors in the A - share market may experience a valuation decline [1]. - **Treasury Bonds**: The current macro - economy is in a stage of steady recovery, structural optimization, and moderate inflation, which is bearish for the bond market. In the short term, it is mainly in a volatile and bearish state, with long - term interest rates under more pressure, while short - term rates are relatively stable due to the support of the capital market [1][2]. Group 3: Summary by Relevant Catalogs 1. Research Views - **Stock Index**: The market showed a bottom - up trend, and the three major indices had different performances. The US - Iran conflict and the Fed's stance led to increased risk - aversion in the capital market. The A - share technology sector may face valuation adjustments in the medium term. The view is that the market will be volatile [1]. - **Treasury Bonds**: Treasury futures closed with gains across different maturities. The central bank conducted reverse repurchases, resulting in a net capital injection. The current economic situation is bearish for the bond market, with short - term volatility and long - term pressure on interest rates. The view is that the market will be volatile [1][2]. 2. Daily Price Changes - **Stock Index Futures**: IH decreased by 0.07%, IF decreased by 0.30%, IC increased by 0.02%, and IM decreased by 0.19%. The Shanghai Composite Index 50 decreased by 0.14%, and the CSI 300 decreased by 0.24%. The CSI 500 increased by 0.21%, and the CSI 1000 increased by 0.28% [3]. - **Treasury Futures**: TS increased by 0.03%, TF increased by 0.08%, T increased by 0.14%, and TL increased by 0.39%. The yields of 2 - year, 5 - year, 10 - year, and 30 - year treasury bonds decreased [3]. 3. Market News - **Overall Trend**: The market rebounded after hitting bottom, with the Shanghai Composite Index rising 0.24%, the Shenzhen Component Index falling 0.25%, and the ChiNext Index falling 0.68%. Over 2,800 stocks rose, and the trading volume was 1.93 trillion yuan [4]. - **Industry Sectors**: Sectors such as non - ferrous aluminum, agriculture, innovative drugs, and commercial aerospace led the gains, while sectors such as power, photovoltaic equipment, oil and gas, and insurance led the losses [4]. - **Hot Concepts**: Non - ferrous aluminum, commercial aerospace, and innovative drug concepts were strong, while power stocks adjusted downward [4]. 4. Chart Analysis 4.1 Stock Index Futures - Provided charts of the trends and basis of IH, IF, IC, and IM futures contracts [6][7][8][9][10]. 4.2 Treasury Futures - Provided charts of the trends, basis, inter - temporal spreads, cross - variety spreads, and capital interest rates of treasury futures contracts [13][14][15][16][17][19]. 4.3 Exchange Rates - Provided charts of the exchange rates of US dollars, euros, pounds, and yen against the Chinese yuan, including spot and forward exchange rates [22][23][25][27][28].

Core Insights - The report identifies a bottom reversal in the weight loss drug theme, indicating potential investment opportunities in this sector [1][3]. Group 1: Theme Outputs - New themes identified include lithium mining, which has shown a right-side breakout [3][6]. - Ongoing trends include hydropower, which has been classified under a right-side trend [3][9]. - New themes showing signs of bottom stabilization include new energy vehicles, robotics, national team stocks, and Hang Seng automotive [3][14]. - Newly identified themes indicating bottom reversal include weight loss drugs, cross-strait integration, low-priced small-cap stocks, and car paint [3][16]. Group 2: Right-Side Breakout Opportunities - Lithium mining index has a 5% fund holding ratio, with a 5-day increase of 17% and a year-to-date increase of 3% [7]. - Photovoltaic inverter index has a 10% fund holding ratio, with a 5-day decrease of 5% but a year-to-date increase of 12% [7]. Group 3: Right-Side Trend Opportunities - Hydropower index has a 3% fund holding ratio, with a 5-day increase of 5% and a year-to-date increase of 11% [9]. Group 4: Bottom Stabilization Opportunities - New energy vehicle index has a 2% fund holding ratio, with a 5-day increase of 0% and a year-to-date decrease of 5% [14]. - Robotics index has a 4% fund holding ratio, with a 5-day increase of 1% and a year-to-date decrease of 13% [14]. - National team index has a 4% fund holding ratio, with a 5-day decrease of 2% and a year-to-date decrease of 5% [14]. Group 5: Bottom Reversal Opportunities - Weight loss drug index has a 7% fund holding ratio, with a 5-day increase of 2% and a year-to-date decrease of 5% [16]. - CAR-T therapy index has a 7% fund holding ratio, with a 5-day increase of 1% and a year-to-date decrease of 2% [16]. - Innovative drug index has a 7% fund holding ratio, with a 5-day increase of 3% and a year-to-date decrease of 3% [16].

Group 1: Report Investment Rating - No information provided Group 2: Core Viewpoints - On March 30, the contracts of the four major index futures in the current month showed mixed trends. IF fell by 0.21%, IH by 0.16%, IC rose by 0.19%, and IM by 0.22% [1] - On this trading day, the total trading volume of index futures rebounded, indicating an increase in investors' trading enthusiasm. Specifically, the total trading volume of IF increased by 4,728 lots, IH by 1,629 lots, IC by 3,084 lots, and IM by 10,930 lots. In terms of positions, the total positions of IF decreased by 5,068 lots, IH by 427 lots, IC by 6,186 lots, while IM increased by 3,733 lots [2] - The trend strength of IF and IH is 1, and that of IC and IM is also 1 [6] - The A - share market bottomed out and rebounded. The Shanghai Composite Index closed up 0.24% at 3,923.29 points, the Shenzhen Component Index fell 0.25%, the ChiNext Index fell 0.68%, and the Wind All - A Index rose 0.05%. The market turnover was 1.93 trillion yuan, compared with 1.86 trillion yuan the previous day [7] - The Hong Kong Hang Seng Index closed down 0.81% at 24,750.79 points; the Hang Seng Technology Index dropped 1.84%, hitting a new low since early April last year; the Hang Seng China Enterprises Index fell 0.65%. Four new stocks were listed on the same day, with PolarView up 150%, Deshizhang 111%, and Han Tian Tian Cheng up 35%. Southbound funds sold a net of nearly HK$2.5 billion [8] - The three major U.S. stock indexes closed mixed. The Dow Jones Industrial Average rose 0.11% to 45,216.14 points, the S&P 500 Index fell 0.39% to 6,343.72 points, and the Nasdaq Composite Index fell 0.73% to 20,794.64 points [8] Group 3: Summary by Related Catalogs 1. Index Futures Data Tracking - **IF Contracts**: The closing price of IF2604 was 4,472.4, down 0.21%, with a basis of - 19.55, a turnover of 36.26 billion yuan, a trading volume of 27,179 lots (up 1,689 lots), and an open interest of 49,894 lots (down 442 lots). Similar data are provided for IF2605, IF2606, and IF2609 [1] - **IH Contracts**: The closing price of IH2604 was 2,829, down 0.16%, with a basis of - 4.21, a turnover of 1.059 billion yuan, a trading volume of 12,534 lots (up 940 lots), and an open interest of 20,218 lots (down 240 lots). Similar data are provided for IH2605, IH2606, and IH2609 [1] - **IC Contracts**: The closing price of IC2604 was 7,706.8, up 0.19%, with a basis of - 46.92, a turnover of 5.728 billion yuan, a trading volume of 37,502 lots (down 1,329 lots), and an open interest of 56,827 lots (down 3,413 lots). Similar data are provided for IC2605, IC2606, and IC2609 [1] - **IM Contracts**: The closing price of IM2604 was 7,695.8, up 0.22%, with a basis of - 72.13, a turnover of 8.387 billion yuan, a trading volume of 55,003 lots (up 2,157 lots), and an open interest of 80,186 lots (down 11 lots). Similar data are provided for IM2605, IM2606, and IM2609 [1] 2. Top 20 Member Position Changes - **IF Contracts**: For IF2604 and IF2605, the long - order increase was 341 (not announced for some), and the short - order increase was 698 (not announced for some). For IF2606, the long - order decrease was 2,480, and the short - order decrease was 2,997. For IF2609, the long - order decrease was 733, and the short - order decrease was 895 [5] - **IH Contracts**: For IH2604, the long - order decrease was 36, and the short - order decrease was 226. For IH2606, the long - order increase was 72, and the short - order increase was 276. For IH2609, the long - order increase was 537, and the short - order increase was 393 [5] - **IC Contracts**: For IC2604, the long - order decrease was 2,647, and the short - order decrease was 2,430. For IC2606, the long - order decrease was 2,165, and the short - order decrease was 1,504. For IC2609, the long - order decrease was 1,000, and the short - order decrease was 909 [5] - **IM Contracts**: For IM2604, the long - order increase was 1,257, and the short - order increase was 233. For IM2605, the long - order net change was 1,614, and the short - order net change was 74. For IM2606, the long - order increase was 357, and the short - order decrease was 159 [5] 3. Important Drivers - U.S. President Trump stated that Iran has agreed to "most of the content" in the "15 - point cease - fire plan". The U.S. is in serious consultations with Iran to end the military operation in Iran. Trump threatened to destroy all of Iran's power plants, oil wells, and Kharg Island, and possibly all desalination plants if an agreement cannot be reached in the short term. The White House Press Secretary said Trump hopes to reach an agreement with Iran by April 6 and intends to call on Arab countries to bear the cost of the U.S. military operation against Iran [6] - Iran stated that if its power facilities are attacked, it will cause a power outage in the entire region. The Iranian President said that ending the war will be based on safeguarding national dignity, interests, and security. The Iranian Foreign Ministry spokesman said that Iran has not had any direct negotiations with the U.S. so far, and the so - called "15 - point cease - fire plan" of the U.S. is "excessive and unreasonable" [6] - The Iranian Parliament's National Security and Foreign Policy Commission passed a bill to charge fees for ships passing through the Strait of Hormuz, including implementing a financial arrangement and charging system in Iranian rials, banning U.S. and Israeli ships from passing through, and cooperating with Oman to formulate relevant legal frameworks [7] - Federal Reserve Chairman Powell said that in the context of the energy shock caused by the U.S. and Israel's war against Iran, the Fed tends to keep interest rates unchanged and temporarily "ignore" the impact. But he also warned that if price increases start to change the public's long - term inflation expectations, the Fed may not be able to stand by [7]

Group 1 - The article emphasizes the importance of focus and attention as the most valuable capital, suggesting that without it, one cannot seize opportunities in the market [1] - Recent discussions have revolved around sectors such as energy storage, computing power, and innovative pharmaceuticals, highlighting the need to identify main lines and leading companies within these sectors [1] - Specific investment opportunities have been identified, such as lithium materials and lithium mines, particularly those with quality domestic sources, as well as companies like Fucjing Technology and Changfei Optical Fiber related to the Faraday optical slice catalysis theme [1] Group 2 - The article discusses the Santa Fe artificial stock market, noting that while the content is significant, it receives less attention compared to articles focused on market trends and formulas, indicating a general preference for practical techniques over philosophical inquiries [2] - It is suggested that understanding one's ecological niche and knowing what to engage with or avoid is more crucial than merely applying formulas, particularly in the context of the electricity sector [2] - The article advises against increasing exposure to physical assets unless a foundational understanding of first principles and underlying philosophies is established, as superficial knowledge is deemed ineffective [2]

Core Views - The A-share market is showing resilience with a clear structural differentiation, indicating that the index may experience fluctuations in the short term while consolidating support [2][10] - The external influences on the A-share market are diminishing, with the market's own recovery momentum taking precedence [3][12] - The market is characterized by a "hot and cold" sector performance, with strong movements in innovative pharmaceuticals and agriculture, while previously popular sectors like green electricity are retreating [12][10] Market Overview - On Monday, the three major indices opened lower but rebounded, with the Shanghai Composite Index showing strength [5][10] - The trading volume remained around 2 trillion yuan, indicating a potential slowdown in the influx of new capital [12][10] - The overall sentiment in the market is moderate, with a general trend of more stocks rising than falling [6] Sector Analysis - Agricultural stocks, particularly in grain and farming, have seen an increase due to stabilizing domestic grain prices and rising overseas prices influenced by geopolitical tensions [7][10] - Aerospace and military stocks are performing well, driven by geopolitical conflicts and the emphasis on "self-control" in key technologies, which enhances the competitive landscape for domestic military enterprises [8][10] - The industrial and precious metals sectors are recovering, supported by ongoing economic growth policies and improving supply-demand dynamics [9][10] Investment Opportunities - Focus on companies that have been unjustly punished but can validate their growth logic through Q1 performance, as these firms are better positioned to withstand market volatility [3][12] - The long-term outlook for the A-share market remains positive, supported by China's diversified energy structure and stable growth policies [13][3]

Core Insights - The report emphasizes the importance of discovering valuable insights rather than merely relaying information [1] Domestic Financial Market - The Shanghai Composite Index closed at 3923.29, with a slight increase of 0.24% [2] - The Shenzhen Component Index closed at 13726.19, reflecting a decrease of 0.25% [2] - The ChiNext Index closed at 3273.36, down by 0.68% [2] Macro News Summary - The central bank held a financial stability meeting to promote capital replenishment through multiple channels [4] - The State Council is studying policies to accelerate the construction of a hierarchical diagnosis and treatment system [4] - The Shanghai Stock Exchange is enhancing the coordination of investment and financing functions in the capital market through a "three-pronged approach" [4] Industry Updates - The Chinese innovative drug sector is experiencing a strong start in 2026, presenting opportunities for investment in companies like Rongchang Biopharma (688331) and Baicheng Pharmaceutical (301096) [5] - The German government is investing over 60 billion in wind power, indicating a potential new upward cycle for the wind energy industry, with related companies including Daikin Heavy Industries (002487) and Tianneng Wind Power (002531) [5] - Non-linear growth in energy storage demand is expected to reshape profitability in the electrolyte segment, with potential beneficiaries like Yongtai Technology (002326) and Tianci Materials (002709) [5] Company Focus - Kema Technology (301611) received approval from the China Securities Regulatory Commission for a convertible bond issuance [6] - Aide Biological (300685) has obtained III class medical device registration for its c-Met gene amplification testing kit [6] - Sanhuan Group (300408) has achieved full-scale production of its MLCC products in all packaging sizes [6] - Oni Electronics (301189) signed a strategic cooperation agreement with Muxi Co., Ltd. to jointly develop a series of desktop AI workstation products [6] Market Review and Outlook - On March 30, the market rebounded, with the Shanghai index turning positive after a drop of over 1%, while the ChiNext and Shenzhen Component indices narrowed their losses [7] - The total trading volume in the Shanghai and Shenzhen markets reached 1.92 trillion, an increase of 626 billion from the previous trading day [7] - The healthcare sector showed significant activity, with notable performances from companies like Meinuohua and Tianyao Pharmaceutical [7] - Defensive sectors such as public utilities and banking saw gains, while energy-related sectors like coal and electricity benefited from energy substitution logic [7]

Core Insights - The report highlights a focus on the transportation sector, particularly oil shipping, which is expected to maintain high prices due to ongoing geopolitical tensions in the Middle East [3][14] - The innovative pharmaceutical sector is identified as having dual support from declining US Treasury yields and strong outbound business development, making it a key area for investment [11] - The report suggests that the A-share market may see a breakthrough opportunity in April, supported by domestic fundamentals and long-term capital [12] Transportation Sector - Oil shipping is currently experiencing low vessel traffic through the Strait of Hormuz, with only about 10 vessels passing daily since the onset of conflict, indicating a rebalancing in the global oil shipping market [14] - China National Airlines is projected to see stable revenue growth in 2025, although it remains unprofitable, indicating a transitional phase in its financial recovery [14] - The new regulations for unmanned aerial vehicles in Beijing, effective May 1, 2026, will enforce stricter management of airspace and outdoor flights [14] Industry Performance - The report notes that the social services sector has seen a decline of 5.46% in the past two weeks, ranking 17th among 31 sectors, with travel and retail sectors particularly affected [19] - The upcoming Qingming Festival and spring break are expected to boost travel demand significantly, with a notable increase in search and booking activity for flights and accommodations [20] Investment Recommendations - The report recommends focusing on opportunities in the oil shipping, dry bulk, and container shipping sectors due to the evolving geopolitical landscape [16] - Specific stocks such as China Merchants Energy and China National Offshore Oil are highlighted for potential investment [16] - The report also suggests monitoring the recovery of the cross-border e-commerce logistics and engineering logistics sectors, with specific companies recommended for investment [17]